|
|
Other links at Articles > Rheumatology |
| 1. |
TNF Antagonists Not Linked to Major Malignant Lymphoma Risk in RA Patients
|
|
|
Anti-tumor necrosis factor (TNF) therapy does not markedly increase the risk of malignant lymphoma in patients with rheumatoid arthritis, according to the results of a Swedish study. This study is one of the largest to-date to assess effects of anti-TNF therapy in rheumatoid arthritis patients. Reuters Health Information
|
| 2. |
Childhood Systemic Sclerosis
|
|
|
Juvenile systemic sclerosis has a variety of clinical manifestations, and can be different from the adult form. The benefit of early recognition, classification and treatment on outcome is reviewed.
Current Opinion in Rheumatology
|
| 4. |
Golimumab Shows Promise Against Rheumatoid Arthritis
|
|
|
Golimumab, a new human anti-TNF alpha antibody, appears beneficial in patients with active rheumatoid arthritis (RA), researchers report in a January 28th online paper in Arthritis and Rheumatism. Reuters Health Information
|
|
|
